Research
Custom MRI tool could show within weeks if pancreatic cancer treatment is working
The Brief
- About 60% of people diagnosed with pancreatic cancer are not eligible for surgery because their disease is too advanced.
- For these patients, treatment typically starts with chemotherapy, in the hope that the tumor shrinks enough to be surgically removed.
- A custom MRI tool is reported to potentially show within weeks whether this treatment is working.
Why it matters
If the MRI approach works, clinicians could judge chemotherapy response within weeks rather than waiting longer, in a cancer where most patients are not surgical candidates at diagnosis.
Who’s affected
- pancreatic cancer patients and their clinicians
- medical imaging and oncology researchers
About 60% of people diagnosed with pancreatic cancer don't qualify for surgery because their disease is too advanced. For these patients, treatment typically begins with chemotherapy, in the hope that the tumor will shrink enough to be surgically removed, which offers the best…